drugset / Trial / NCT00211900
Evaluation of Manufacturing Lot of StaphVAX
Non-randomizedSingle-groupOpen-labelPrevention
Summary
This study answers a U.S. Food and Drug Administration requirement for evaluation in people of a manufacturing lot of vaccine. Subjects receive one dose of one lot of vaccine. The antibodies in the blood measure the immunogenicity of the vaccine, and typical vaccine safety information is also collected.
Timeline
- Start
- 2005-03
- Primary completion
- 2005-08
- Completion
- 2005-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | StaphVAX | Vaccine | 200 ug | Intramuscular |